The aim of the new addendum is introducing improved and more effective approaches to design development, clinical trials, monitoring of their progress, documentation and reporting, and standards for the maintenance of electronic documentation and mandatory...
On April 15th at 11:00 a.m. , we will hold the webinar on “GCP for Drug developers (Sponsors). Quality Assurance system organization” . Poorly conducted clinical trials mean the lack of them. Quality and safety is the foundation of the pharmaceutical...
On April 19th at 11:00 a.m. , we will hold the webinar on “GCP for Investigators. Quality assurance system organization in investigator sites” . Organization of quality system is important for the Sponsors and for the investigator sites. Quality...